GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 191 filers reported holding GENMAB A/S in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $79,131,772 | -7.2% | 2,243,600 | 0.0% | 0.11% | +10.9% |
Q2 2023 | $85,279,236 | +0.7% | 2,243,600 | 0.0% | 0.10% | -17.9% |
Q1 2023 | $84,718,336 | -12.6% | 2,243,600 | -1.9% | 0.12% | -23.6% |
Q4 2022 | $96,948,488 | +31.9% | 2,287,600 | -0.0% | 0.16% | +17.5% |
Q3 2022 | $73,521,000 | +69.4% | 2,288,246 | +71.3% | 0.14% | +80.3% |
Q2 2022 | $43,403,000 | -25.6% | 1,335,900 | -18.3% | 0.08% | -8.4% |
Q1 2022 | $58,373,000 | -17.5% | 1,635,900 | -6.8% | 0.08% | -33.6% |
Q4 2021 | $70,724,000 | -5.5% | 1,755,923 | +0.0% | 0.12% | -10.7% |
Q3 2021 | $74,820,000 | +2.9% | 1,755,900 | 0.0% | 0.14% | -0.7% |
Q2 2021 | $72,679,000 | +39.9% | 1,755,900 | +7.7% | 0.14% | +25.9% |
Q1 2021 | $51,959,000 | -24.4% | 1,630,000 | -3.0% | 0.11% | -30.4% |
Q4 2020 | $68,700,000 | +30.5% | 1,680,000 | +20.0% | 0.16% | +17.5% |
Q3 2020 | $52,633,000 | +240.4% | 1,400,000 | +197.9% | 0.14% | +197.8% |
Q2 2020 | $15,460,000 | +646.5% | 470,000 | +368.1% | 0.05% | +557.1% |
Q1 2020 | $2,071,000 | – | 100,400 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 242,848 | $9,169,940 | 3.80% |
Capricorn Fund Managers Ltd | 110,643 | $4,177,880 | 1.28% |
Arlington Capital Management, Inc. | 35,591 | $1,343,916 | 1.26% |
XY Capital Ltd | 76,884 | $2,903,140 | 1.13% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 88,000 | $3,322,880 | 0.93% |
TORRAY INVESTMENT PARTNERS LLC | 110,807 | $4,184,072 | 0.75% |
Hardman Johnston Global Advisors LLC | 585,139 | $22,094,849 | 0.72% |
Yorktown Management & Research Co Inc | 16,600 | $626,816 | 0.68% |
First Light Asset Management, LLC | 160,025 | $6,042,544 | 0.54% |
MIRABELLA FINANCIAL SERVICES LLP | 28,260 | $2,505,855 | 0.38% |